Medical Developments International (MDI)
Scott Courtney is an accomplished professional in the field of scientific research and operations within the pharmaceutical and biotechnology sectors. Currently serving as Chief Scientific Officer at Medical Developments International since February 2012, Scott has held multiple leadership roles including Director of Operations & Research and Director of Research & Development. Prior to this, Scott was the Managing Director at Boron Molecular Pty Ltd from March 2007 to July 2011 and also held the position of Production & Operations Manager at Boron Molecular from July 2005 to March 2007. Additionally, Scott worked at the Institute of Drug Technology from 1999 to 2005 as Production Manager and Corporate Support Manager. Educationally, Scott holds a PhD in BioInorganic Chemistry and a Bachelor of Science in Organic Chemistry, both from Monash University.
This person is not in any teams
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.